|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Journal of Lipid Research, Vol. 48, 869-881, April 2007
Copyright © 2007 by American Society for Biochemistry and Molecular Biology
Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, TX 75390-8887
Published, JLR Papers in Press, January 14, 2007.
1 To whom correspondence should be addressed. e-mail: stephen.turley{at}utsouthwestern.edu
Niemann-Pick type C (NPC) disease is a multisystem disorder resulting from mutations in the NPC1 gene that encodes a protein involved in intracellular cholesterol trafficking. Significant liver dysfunction is frequently seen in patients with this disease. The current studies used npc1 mutant mice to investigate the association between liver dysfunction and unesterified cholesterol accumulation, a hallmark of NPC disease. Data from 92 npc1/ mice (age range, 956 days) revealed a significant positive correlation between the plasma activities of alanine aminotransferase (ALT) and aspartate aminotransferase (AST) and whole liver cholesterol content. In 56 day old npc1/ mice that had been fed from 35 days of age a rodent diet or the same diet containing either cholesterol (1.0%, w/w) or ezetimibe (a sterol absorption inhibitor; 0.0125%, w/w), whole liver cholesterol content averaged 33.5 ± 1.1, 87.9 ± 1.7, and 20.8 ± 0.9 mg, respectively. Again, plasma ALT and AST activities were positively correlated with hepatic cholesterol content. In contrast, plasma transaminase levels remained in the normal range in npc1+/+ mice, in which hepatic esterified cholesterol content had been increased by 72-fold by feeding a high-cholesterol, high-fat diet. These studies suggest that the late endosomal/lysosomal content of unesterified cholesterol correlates with cell damage in NPC disease.
Supplementary key words hepatic dysfunction chylomicron cholesterol low density lipoprotein receptor biliary bile acid hepatomegaly small intestine
Abbreviations: ALT, alanine aminotransferase; apoE, apolipoprotein E; AST, aspartate aminotransferase; bw, body weight; CMr, chylomicron remnant; LDLR, low density lipoprotein receptor; NPC, Niemann-Pick type C; NPC1L1, Niemann-Pick C1-Like 1; VLDLr, very low density lipoprotein remnant
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
H. Li, S. D. Turley, B. Liu, J. J. Repa, and J. M. Dietschy GM2/GD2 and GM3 gangliosides have no effect on cellular cholesterol pools or turnover in normal or NPC1 mice J. Lipid Res., August 1, 2008; 49(8): 1816 - 1828. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Liu, H. Li, J. J. Repa, S. D. Turley, and J. M. Dietschy Genetic variations and treatments that affect the lifespan of the NPC1 mouse J. Lipid Res., March 1, 2008; 49(3): 663 - 669. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. J. Repa, H. Li, T. C. Frank-Cannon, M. A. Valasek, S. D. Turley, M. G. Tansey, and J. M. Dietschy Liver X Receptor Activation Enhances Cholesterol Loss from the Brain, Decreases Neuroinflammation, and Increases Survival of the NPC1 Mouse J. Neurosci., December 26, 2007; 27(52): 14470 - 14480. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Liu, C. Xie, J. A. Richardson, S. D. Turley, and J. M. Dietschy Receptor-mediated and bulk-phase endocytosis cause macrophage and cholesterol accumulation in Niemann-Pick C disease J. Lipid Res., August 1, 2007; 48(8): 1710 - 1723. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Journal of Biological Chemistry |
| Molecular and Cellular Proteomics | ASBMB Today |